Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

Citation
M. Hayashi et al., Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction, J AM COL C, 37(7), 2001, pp. 1820-1826
Citations number
31
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN journal
07351097 → ACNP
Volume
37
Issue
7
Year of publication
2001
Pages
1820 - 1826
Database
ISI
SICI code
0735-1097(20010601)37:7<1820:IANPPL>2.0.ZU;2-Y
Abstract
OBJECTIVES The study evaluates the effect of atrial natriuretic peptide (AN P) compared with nitroglycerin (GTN) on left ventricular (LV) remodeling af ter first anterior acute myocardial infarction (AMI). BACKGROUND Compared with GTN, ANP suppresses the renin-angiotensin-aldoster one system and endothelin-1 (ET-1), which stimulate LV remodeling. METHODS Sixty patients with a first anterior AMI were randomly divided into the ANP (n = 30) or GTN (n = 30) groups after direct percutaneous translum inal coronary angioplasty. We evaluated LV ejection fraction (LVEF), end-di astolic volume index (LVEDVI) and endsystolic volume index (LVESVI) at the acute phase and after one month. We also measured neurohumoral factors duri ng study drug infusion. RESULTS There nas no difference in the baseline characteristics or LVEF (46 .9 +/- 1.0 vs. 46.8 +/- 1.3%) between the two groups. Although there was no difference in hemodynamics during the infusion periods, the LVEF tvas sign ificantly improved after one month compared with the baseline value in both groups, but it was improved more in the ANP group than in the GTN group (5 4.6 +/- 1.1%, 50.8 +/- 1.3%, p < 0.05). Left ventricular enlargement was pr evented in the ANP group (LVEDVI, 85.8 +/- 3.1 ml/m(2) to 87.3 +/- 2.7 ml/m (2); p = ns, LVESVI, 45.6 +/- 1.8 ml/m(2) to 41.0 +/- 2.1 ml/m(2), p < 0.05 ) but not in the GTN group (LVEDVI, 86.2 +/- 4.1 to 100.2 +/- 3.7, p < 0.01 ; LVESVI, 46.3 +/- 2.8 ml/m(2) to 51.1 +/- 3.0 ml/m(2), p = ns). During the infusion, ANP suppressed plasma levels of aldosterone, angiotensin II and ET-1 compared with GTN. CONCLUSIONS These findings indicate that in patients with a first anterior AMI, an ANP infusion can prevent LV remodeling better than can GTN, and eff ectively suppresses aldosterone, angiotensin II and ET-1. (J Am Coll Cardio l 2001;37:1820-6) (C) 2001 by the American College of Cardiology.